Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2257 per EA under NDC 31722044590. Its NADAC has been published 33 times since Jan 7, 2026.
FDA first approved this application on Feb 14, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5; 20 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722044590
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209591FDA Approved
2/14/2025
TE Code
AB
On Market Since
2/14/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 33 times since Jan 7, 2026, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2257 per EA |
|---|---|
| All-time high | $0.2476 (Jul 15, 2026) |
| All-time low | $0.2257 (Aug 19, 2026) |
| 52-week high | $0.2476 |
| 52-week low | $0.2257 |
| Median price | $0.2424 |
| Average price | $0.2416 |
| Largest weekly change | -7.7% (Aug 19, 2026) |
| Weeks tracked | 33 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Camber Pharmaceuticals Inc., is $0.2257 per EA (NDC 31722044590), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 4.6%. It has been tracked across 33 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Jan 7, 2026, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2257 (Aug 19, 2026) to a high of $0.2476 (Jul 15, 2026), with a median of $0.2424 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 5-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 31722044590) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.